The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system

Topic: Brain proteins, microglia and lab models

In Alzheimer disease (AD), deposition of neurofibrillary tangles and loss of synapses in the neocortex and limbic system each correlate strongly with cognitive impairment. Tangles are composed of misfolded hyperphosphorylated tau proteins; however, the link between tau abnormalities and synaptic dysfunction remains unclear. We examined the location of tau in control and AD cortices using biochemical and morphologic methods. We found that, in addition to its well-described axonal localization, normal tau is present at both presynaptic and postsynaptic terminals in control human brains. In AD, tau becomes hyperphosphorylated and misfolded at both presynaptic and postsynaptic terminals, and this abnormally posttranslationally modified tau is enriched in synaptoneurosomal fractions. Synaptic tau seems to be hyperphosphorylated and ubiquitinated, and forms stable oligomers resistant to SDS denaturation. The accumulation of hyperphosphorylated tau oligomers at human AD synapses is associated with increased ubiquitinated substrates and increased proteasome components, consistent with dysfunction of the ubiquitin-proteasome system. Our findings suggest that synaptic hyperphosphorylated tau oligomers may be an important mediator of the proteotoxicity that disrupts synapses in AD.

@article{tai2012-22867711,
  author  = {Tai, H. C. and Serrano-Pozo, A. and Hashimoto, T. and Frosch, M. P. and Spires-Jones, T. L. and Hyman, B. T.},
  title   = {{The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system}},
  journal = {The American journal of pathology},
  year    = {2012},
  doi     = {10.1016/j.ajpath.2012.06.033},
  pmid    = {22867711},
  url     = {https://doi.org/10.1016/j.ajpath.2012.06.033}
}

Key findings

• We found that, in addition to its well-described axonal localization, normal tau is present at both presynaptic and postsynaptic terminals in control human brains.
• The accumulation of hyperphosphorylated tau oligomers at human AD synapses is associated with increased ubiquitinated substrates and increased proteasome components, consistent with dysfunction of the ubiquitin-proteasome system.
• Our findings suggest that synaptic hyperphosphorylated tau oligomers may be an important mediator of the proteotoxicity that disrupts synapses in AD.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/j.ajpath.2012.06.033
• PubMed: 22867711
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Disease mechanisms

• Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease Neurobiology of aging · 2020-12-08 · usefulness score 41/100
• Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis Neuroscience letters · 2019-03-16 · usefulness score 39/100
• Effects of Heparan Sulfate Trisaccharide Containing Oleanolic Acid in Attenuating Hyperphosphorylated Tau-Induced Cell Dysfunction Associated with Alzheimer’s Disease Journal of Medicinal Chemistry · 2025-01-22 · usefulness score 41/100
• Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system Open biology · 2017-04 · usefulness score 39/100
• The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease Molecular neurobiology · 2015-01-07 · usefulness score 38/100
• The ubiquitin-proteasome system in neurodegeneration Antioxidants & redox signaling · 2014-02-27 · usefulness score 38/100

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

• Acetylated tau neuropathology in sporadic and hereditary tauopathies The American journal of pathology · 2013-08-01 · usefulness score 45/100 · Risk genes beyond APOE
• Longitudinal Association of Total Tau Concentrations and Physical Activity With Cognitive Decline in a Population Sample JAMA network open · 2021-08-02 · usefulness score 61/100 · Tau biomarkers
• Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology Clinical chemistry · 2004-11-24 · usefulness score 51/100 · Mild cognitive impairment

Similar studies

• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. 1986 · Disease mechanisms
• Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease 1989 · Brain tissue and pathology
• Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease 2023 · Biomarkers
• Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy 2012 · Laboratory science
• Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies 2022 · Lewy body dementia
• Both total and phosphorylated tau are increased in Alzheimer's disease 2001 · Vascular contributions

More on Disease mechanisms

• A review that covers this ground The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron · 2003-10-01 · usefulness score 36/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →